USP24 suppresses T cell anti-tumor activity by enhancing the stability of the PD-1 protein

被引：0
|
作者：
Hsieh, Hung-Chia
Hung, Jan-Jong
Wang, Yi-Ching
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB445
引用
收藏
页数：2
相关论文
共 50 条
  • [1] UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity
    He, Chuan
    Xing, Xixin
    Chen, Hsin-Yi
    Gao, Minling
    Shi, Jie
    Xiang, Bolin
    Xiao, Xiangling
    Sun, Yishuang
    Yu, Haisheng
    Xu, Gaoshan
    Yao, Yingmeng
    Xie, Zuosong
    Xing, Yujie
    Budiarto, Bugi Ratno
    Chen, Shih-Yu
    Gao, Yang
    Lee, Yu-Ru
    Zhang, Jinfang
    MOLECULAR CELL, 2024, 84 (06) : 1120 - 1138.e8
  • [2] Differential modulation of the PD-1 pathway impacts the anti-tumor activity of CAR T cells
    Lin, Regina J.
    Gautron, Anne-Sophie
    Poirot, Laurent
    Wong, Oi Kwan
    Sasu, Barbra
    Boldajipour, Bijan
    CANCER RESEARCH, 2017, 77
  • [3] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
    Li, Baoqi
    Fang, Tianliang
    Li, Yuan
    Xue, Tianyuan
    Zhang, Zhirang
    Li, Liyan
    Meng, Fanqiang
    Wang, Jinqiang
    Hou, Linlin
    Liang, Xin
    Zhang, Xudong
    Gu, Zhen
    NANO TODAY, 2022, 46
  • [4] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
    Li, Baoqi
    Fang, Tianliang
    Li, Yuan
    Xue, Tianyuan
    Zhang, Zhirang
    Li, Liyan
    Meng, Fanqiang
    Wang, Jinqiang
    Hou, Linlin
    Liang, Xin
    Zhang, Xudong
    Gu, Zhen
    Nano Today, 2022, 46
  • [5] B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors
    Damsky, William
    Jilaveanu, Lucia
    Turner, Noel
    Perry, Curtis
    Zito, Christopher
    Tomayko, Mary
    Leventhal, Jonathan
    Herold, Kevan
    Meffre, Eric
    Bosenberg, Marcus
    Kluger, Harriet M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] Sintilimab: A Promising Anti-Tumor PD-1 Antibody
    Zhang, Lin
    Mai, Wuqian
    Jiang, Wenyang
    Geng, Qing
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] PD-1 BLOCKADE ADMINISTERED BEFORE OR AT THE TIME OF T CELL ACTIVATION ENHANCES ANTI-TUMOR IMMUNITY
    Moseman, Jena
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A492 - A492
  • [8] PD-1 blocking strategy for enhancing the anti-tumor effect of CAR T cells targeted CD105
    Wang, Xi
    Lai, Zhiheng
    Pang, Yanyang
    Sun, Qinghui
    Yang, Wenli
    Wang, Wu
    HELIYON, 2023, 9 (01)
  • [9] Enhancing Anti-tumor Effect of PD-1 Inhibitors through T-Cell Activation by Amino Acid Transporter LAT1 Inhibitor
    Xu, Minhui
    Zhou, Xinyu
    Jin, Chunhuan
    Okanishi, Hiroki
    Ohgaki, Ryuichi
    Endou, Hitoshi
    Kanai, Yoshikatsu
    CANCER SCIENCE, 2024, 115 : 577 - 577
  • [10] Enhanced Anti-tumor Reactivity of Cytotoxic T Lymphocytes Expressing PD-1 Decoy
    Shin, Jae Hun
    Park, Hyung Bae
    Choi, Kyungho
    IMMUNE NETWORK, 2016, 16 (02) : 134 - 139
12345